KRAS-targeting drugs show promise for rare appendix cancer. Targeting mutant KRAS may offer a promising new treatment option for appendix cancer, according to research from The University of Texas MD Anderson Cancer Center published in the Journal of Hematology & Oncology.
A apuração publicada por medicalxpress.com vira base para uma leitura editorial direta e contextualizada.
Trechos de apoio da pauta: Targeting mutant KRAS may offer a promising new treatment option for appendix cancer, according to research from The University of Texas MD Anderson Cancer Center published in the Journal of Hematology & Oncology.
- Ponto de atenção: kras.
- Ponto de atenção: targeting.
- Ponto de atenção: drugs.
Em resumo, a leitura editorial acompanha o impacto do tema no nicho Fitness.
